Reimbursement

Latest News

Medicare’s Drug Negotiation Could Lead to Greater Access — or More Utilization Management
Medicare’s Drug Negotiation Could Lead to Greater Access — or More Utilization Management

October 3rd 2023

Even though the Inflation Reduction Act will require plans to justify formulary placement of negotiated drugs, payers have more of an incentive to steer patients to lower-cost alternatives.

The “Risk” of Value-Based Care
The “Risk” of Value-Based Care

September 7th 2022

  It’s Time to Tame the “Diagnostic-Coding Arms Race”: NEJM Opinion Piece
It’s Time to Tame the “Diagnostic-Coding Arms Race”: NEJM Opinion Piece

July 29th 2022

Another Legal Challenge to the ACA
Another Legal Challenge to the ACA

July 26th 2022

Why Social Determinants of Health Are a Critical Factor for Preventing Member Risk Escalation in the Value-Based Care Equation
Why Social Determinants of Health Are a Critical Factor for Preventing Member Risk Escalation in the Value-Based Care Equation

June 27th 2022

More News

© 2024 MJH Life Sciences

All rights reserved.